Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

Share Price is delayed by 15 minutes
Get Live Data
18.00    -1.00 (-5.26%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £41.30m
GELN Live PriceLast checked at - London Stock Exchange

Intraday Gelion Share Chart

Director Dealing

20 May 2025 07:00

RNS Number : 3747J
Gelion PLC
20 May 2025
 

20 May 2025

Gelion plc

("Gelion" or the "Company")

Director Dealing

Gelion (AIM: GELN), the global energy storage innovator, announces that it received notification that on 19 May 2025 Dr Graham Cooley, Non-Executive Director, purchased 216,668 ordinary shares in the Company ("Ordinary Shares") at an average price of approximately 13.98 pence per Ordinary Share.

As a result of this purchase, Dr Cooley holds 2,550,000 Ordinary Shares, representing 1.44% of the total voting rights of the Company.

 

Enquiries:

Gelion plc John Wood, CEOAmit Gupta, CFO

Prof. Thomas Maschmeyer (Founder and Director)

via Alma

Strand Hanson Limited (Nominated and Financial Adviser)Christopher Raggett / Rob Patrick

+44 (0) 20 7409 3494

Oberon Capital (Joint Broker) Nick Lovering / Mike Seabrook / Adam Pollock

+44 (0) 20 3179 5300

Allenby Capital Limited (Joint Broker)

Jos Pinnington / Guy McDougall (Sales and Corporate Broking)

Alex Brearley / Ashur Joseph (Corporate Finance)

+44 (0) 20 3328 5656

Alma Strategic Communications (Financial PR)Justine James / Hannah Campbell / Will Ellis Hancock

+44 (0) 20 3405 0205 gelion@almastrategic.com

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, as it forms part of UK law.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Dr Graham Cooley

2. 

Reason for the notification

a)

Position/status:

Non-Executive Director

b)

Initial notification/Amendment:

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Gelion plc

b)

LEI:

2138008NC7YL3MCUDR84

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1p each ("Ordinary Shares")

GB00BNBQZD59

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

13.98p

216,668

d)

Aggregated information:

· Aggregated volume:

· Price:

 

Purchase of 216,668 Ordinary Shares

Average price of 13.98p per Ordinary Share

e)

Date of the transaction:

19 May 2025

f)

Place of the transaction:

London Stock Exchange, AIM

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGUGDUUUDDGUG
Date   Source Headline
21st Dec 202312:23 pmRNSResult of AGM
14th Dec 20234:15 pmRNSPosting of Annual Report and Notice of GM
13th Dec 20237:00 amRNSDirector/PDMR Shareholding - Grant of options
12th Dec 202312:00 pmRNSFinal results to 30 June 2023
1st Dec 20237:00 amRNSDirector/PDMR Dealings and Total Voting Rights
30th Nov 202312:40 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSNotice of Results and AGM
27th Nov 20234:54 pmRNSResult of GM and Total Voting Rights
23rd Nov 20237:01 amRNSNotice of Investor Presentation
23rd Nov 20237:00 amRNSResult of Retail Offer and Total Voting Rights
21st Nov 20237:00 amRNSGelion and Ionblox JDA signed
9th Nov 20231:00 pmRNSResult of Placing and Posting of Circular
9th Nov 20238:00 amRNSUK Retail Offer
9th Nov 20237:17 amRNSProposed Acquisition, Placing, Retail Offer and GM
11th Oct 20237:00 amRNSExpanded Li-S R&D Facility launched
15th Aug 20237:00 amRNSTrading update and two new agreements signed
27th Jul 20239:45 amRNSBlock Admission Return
6th Jul 20237:00 amRNSZinc battery solution and Lithium Sulfur update
5th Jul 20237:00 amRNSChange of Registered Office
1st Jun 202312:05 pmRNSDirector/PDMR Shareholding
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20237:19 amRNSStrategic progress on Johnson Matthey IP acq
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20239:15 amRNSDirector/PDMR Shareholding
17th Mar 202310:45 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim results to 31 December 2022
13th Mar 20237:00 amRNSLithium Sulfur IP Acq + Innovation Challenge
9th Mar 20237:00 amRNSAcq. of Johnson Matthey’s battery IP portfolio
1st Mar 20238:17 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSNotice of Results and Investor Presentation
27th Jan 20237:00 amRNSBlock Admission Return
16th Dec 202212:00 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSCEO Board Appointment and Grant of Options
9th Dec 202211:29 amRNSResult of AGM
6th Dec 20229:30 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSProof of performance additive viability
30th Nov 20229:50 amRNSDirector/PDMR Shareholding - Grant of options
24th Nov 202211:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:00 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20227:01 amRNSFinal results to 30 June 2022
9th Nov 20227:00 amRNSAppointment of CEO
20th Oct 20227:00 amRNSNotice of Results and Investor Presentation
13th Oct 202210:20 amRNSIssue of shares and change to total voting rights
30th Sep 20227:00 amRNSFirst industrial production of 'Endure' battery
27th Jul 20227:00 amRNSBlock Admission Return
16th Mar 20227:00 amRNSInterim results
10th Mar 20229:00 amRNSNotice of Results
3rd Mar 20227:00 amRNSBoard and Management Update
28th Feb 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.